Tag Archives: cancer

A Poignant Election Day Comeback

Rep. DeSaulnier (center) with representatives of the American Cancer Society

On Election Day, a day of underdogs and upsets in American politics, Representative Mark DeSaulnier may have scored the greatest comeback of them all. Six months after completing chemotherapy to treat chronic lymphocytic leukemia, he has now beaten cancer and his opponent for California’s 11th district congressional seat. The type of leukemia that was diagnosed in Rep. DeSaulnier is the most common form of blood cancer in adults. Once it goes into remission, the five-year Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Scientists Open New Window into Pancreatic Cancer Research

Greenwood_Jim_BTN

For years, pancreatic cancer has been referred to as the “silent killer.” It is notoriously aggressive, resistant to treatment, and difficult to diagnose in the early stages when tumors are most treatable. Also, it’s location in the body, deep in the abdominal cavity right behind the stomach, makes it hard to detect. These are the primary reasons why it is the fourth deadliest cancer, and the five-year survival rate for those with stage IV pancreatic Read More >

Corporate  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Is Immunotherapy the 4th Pillar of Oncology?

pmwc_2017_mv_180x110

In contrast to the three traditional pillars of cancer treatment (surgery, radiotherapy, and chemotherapy), cancer immunotherapy is a relatively young field, yet it is considered a huge game-changer – as it is in the process of changing how we treat cancer. Immunotherapy is rapidly becoming part of the toolbox for treatment of various types of cancers, in some cases already establishing a new standard of care. Take the example of melanoma which will have about 76,000 Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Cancer Docs Weigh in on Medicare Part B Demo

medical_research

This week, American Society of Clinical Oncology (ASCO) President Daniel Hayes, MD and CEO Clifford Hudis, MD shared their thoughts in The Hill on how “We can do better than Medicare Part B demo.” At the forefront of oncology, they remind us that we are living in remarkable times of real progress – treatment options are ever-improving as is the number of cancer survivors. However, the experimental nature of Medicare Part B demo poses a Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

WSJ: A Piece of the Immunotherapy Puzzle Solved

Just two weeks ago, the New York Times published a series of articles deeming immunotherapy as the future for cancer advances and new life-saving treatments – even though it’s not entirely clear why only some patients have success with the treatments. This week, the Wall Street Journal joined the immunotherapy conversation by highlighting two researchers who may have unlocked part of the mystery as to why only some patients benefit from immunotherapy. When Dr. Michael Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,